The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate (Q40695042)
Jump to navigation
Jump to search
scientific article published on 12 September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate |
scientific article published on 12 September 2002 |
Statements
1 reference
The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate (English)
1 reference
Michael Hallek
1 reference
Christine Schuster
1 reference
Karin Forster
1 reference
Henning Dierks
1 reference
Annika Elsasser
1 reference
Gerhard Behre
1 reference
Nicola Simon
1 reference
Susanne Danhauser-Riedl
1 reference
Markus Warmuth
1 reference
12 September 2002
1 reference
Identifiers
1 reference